The family of ribosome-inactivating proteins (RIPs) groups all enzymes (EC.3.2.2.22) with a so-called RIP domain which comprises N-glycosidase activity and enables these proteins to catalytically inactivate ribosomes. Ever since the discovery of the first ribosome-inactivating protein, this group of plant toxins has received a lot of attention from researchers in various fields. Ribosome-inactivating proteins have been studied in detail for their distribution in nature, their molecular structure and toxicity, and have proven valuable tools for agricultural and biomedical research. Despite their long history ribosome-inactivating proteins are still at the forefront of research on applicability of plant toxins.
In view of applications as anti-cancer agents, it is important that the selectivity, immunogenicity, half-life and toxicity of RIP-based conjugates are investigated. Therefore Chooniedass et al. [5] studied the engineering and biological activity of different conjugates containing the plant toxin deBouganin for their interaction with a panel of breast cancer cell lines. In an attempt to adapt ribosome-inactivating proteins for clinical use, Sun et al. [6] investigated the production, identification and anti-tumour activity of mono-pegylated ribosome-inactivating proteins from Momordica charantia.
Ribosome-inactivating proteins are widely distributed in flowering plants. Shang et al. [7] report on the occurrence of ribosome-inactivating proteins in the family Rosaceae. They retrieved multiple RIP sequences from the genomes of Malus domestica, Prunus persica, Prunus mume, Pyrus communis and Pyrus brestschneideri but not from the genomes of Fragaria vesca and Fragaria ananassa. The results of in silico analysis and molecular modelling revealed that the amino acids known to be important for the activity of ricin are highly conserved in the active site of the RIP sequences from Malus domestica, suggesting that these ribosome-inactivating proteins are functional proteins, as also inferred from data of translation inhibition experiments with recombinant ribosome-inactivating proteins from apple.
Extracts from different elderberry (Sambucus nigra) tissues as well as elderberry juices are a rich source of lectins, ribosome-inactivating proteins and low molecular weight nutraceuticals. Jiminez et al. [8] report that short-time heat treatment of extracts reduced potential allergy-related risks derived from elderberry consumption, but did not compromise the anti-oxidant properties and free-radical scavenging activities. Future in vivo studies will have to address questions related to lectin digestibility in animals and in food matrices.
This Special Issue provides the readers with several up-to-date overview papers and original research articles that highlight the state-of-the-art of research on ribosome-inactivating proteins and their prospects for applications.
